NBQX treatment improves mitochondrial function and reduces oxidative events after spinal cord injury

Journal of Neurotrauma

Volumn 19, Issue 8, 2002, Pages 917-927

  Mu, Xiaojun ^a   Azbill, Robert D ^a   Springer, Joe E ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Glutamate receptors; Mitochondrial function; MK 801; NBQX; Spinal cord injury

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; DIZOCILPINE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CELL DESTRUCTION; CONTROLLED STUDY; CONTUSION; DRUG EFFECT; DRUG EFFICACY; GLUCOSE METABOLISM; LIPID PEROXIDATION; MITOCHONDRIAL MEMBRANE; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; RAT; RECEPTOR BLOCKING; SPINAL CORD INJURY; SYNAPTOSOME;

EID: 0036676084     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/089771502320317078     Document Type: Article

References (92)

1. Role of NMDA and non-NMDA ionotropic glutamate receptors in traumatic spinal cord axonal injury
2. Pathophysiology of spinal cord trauma
3. Impaired mitochondrial function, oxidative stress and altered antioxidant enzyme activities following traumatic spinal cord injury
4. Lipid peroxidation in experimental spinal cord injury: Time-level relationship
5. Mitochondria, free radicals, and neurodegeneration
6. The relationship between excitotoxicity and oxidative stress in the central nervous system
7. Oxidative stress induced by glutamate receptor agonists
8. Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation
9. Involvement of lipid peroxidation in CNS injury
10. Prevention of post-traumatic excitotoxic brain damage with NMDA antagonist drugs: A new strategy for the nineties
11. Oxidative stress, glutamate, and neurodegenerative disorders
12. Effect of impact trauma on neurotransmitter and nonneurotransmitter amino acids in rat spinal cord
13. Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate
14. +: Implications for neurodegeneration
15. Free radicals in brain metabolism and pathology
16. A potential role for excitotoxins in the pathophysiology of spinal cord injury
17. N-Methyl-D-aspartate antagonist MK-801 improves outcome following traumatic spinal cord injury in rats: Behavioral, anatomical, and neurochemical studies
18. The role of excitatory amino acids and NMDA receptors in traumatic brain injury
19. Effects of competitive and non-competitive NMDA receptor antagonists in spinal cord injury
20. Changes of extracellular levels of amino acids after graded compression trauma to the spinal cord: An experimental study in the rat using microdialysis
21. Effects of methylprednisolone on extracellular lactic acidosis and amino acids after severe compression injury of rat spinal cord
22. Effect of 21-aminosteroid on extracellular energy-related metabolites and amino acids after compression injury of rat spinal cord
23. 45Ca autoradiographic study
24. Free radical damage to protein and DNA: Mechanisms involved and relevant observations on brain undergoing oxidative stress
25. Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal
26. Antagonists of excitatory amino acids and endogenous opioid peptides in the treatment of experimental central nervous system injury
27. Glutamate release and free radical production following brain injury: Effects of posttraumatic hypothermia
28. Neuroprotective effect of MK-801 and U-50488H after contusive spinal cord injury
29. Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid beta-peptide toxicity
30. Changes in extracellular amino acid neurotransmitters produced by focal cerebral ischemia
31. NMDA receptor activation produces concurrent generation of nitric oxide and reactive oxygen species: Implication for cell death
32. Pretreatment with NMDA receptor antagonist MK-801 improves neurophysiological outcome after an acute spinal cord injury
33. Free radicals and CNS injury
34. Lipid antioxidants in acute central nervous system injury
35. The role of oxygen radicals in traumatic injury: Clinical implications
36. Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation
37. Antioxidant effects in brain and spinal cord injury
38. Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury
39. Dihyrorhodamine 123: A fluorescence probe for superoxide generation?
40. Effects of superoxide radicals on transport (Na+K) adenosine triphosphatase and protection by superoxide dismutase
41. MK 801, an OBS N-methyl-D-aspartate channel blocker, does not improve the functional recovery nor spinal cord blood flow after spinal cord compression in rats
42. Oxygen-free radicals in traumatic brain oedema
43. 2+ ATPase activity, lipid peroxidation and ultrastructural findings following experimental spinal cord injury with and without intravenous methylprednisolone treatment
44. +-ATPase activity by oxygen free radicals
45. White matter injury in spinal cord ischemia: Protection by AMPA/kainate glutamate receptor antagonism
46. Calcium-dependent glutamate release concomitant with massive potassium flux during cerebral ischemia in vivo
47. 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes
48. Impairment of glucose and glutamate transport, and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid-beta peptide: Role of the lipid peroxidation product 4-hydroxynonenal
49. Peroxynitrite-mediated oxidation of dihydrorhodamine 123
50. NMDA-dependent superoxide production and neurotoxicity
51. Action of locally administered NMDA and AMPA/kainate receptor antagonists in spinal cord injury
52. NMDA and non-NMDA receptor antagonists protect against excitotoxic injury in the rat spinal cord
53. Neurotoxicity of glutamate at the concentration released upon spinal cord injury
54. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid-beta peptide
55. Calcium, free radicals, and excitotoxic neuronal death in primary cell culture
56. 2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons
57. Evidence that reversed glutamate uptake contributes significantly to glutamate release following experimental injury to the rat spinal cord
58. Lipid peroxidation and the role of oxygen radicals in CNS injury
59. Changes in metabotropic glutamate receptor expression following spinal cord injury
60. Role of group II and group III metabotropic glutamate receptors in spinal cord injury
61. Involvement of metabotropic glutamate receptors in excitatory amino acid and GABA release following spinal cord injury in rat
62. 21-Aminosteroids attenuate excitotoxic neuronal injury in cortical cell cultures
63. Riluzole and methylprednisolone combined treatment improves functional recovery in traumatic spinal cord injury
64. Riluzole improves measures of oxidative stress in traumatic spinal cord injury
65. The use of tetrazolium salts to determine sites of damage to the mitochondrial electron transport chain in intact cells following in vitro photodynamic therapy with photofrin II
66. Spinal neuronal pathology associated with continuous intrathecal infusion of N-methyl-D-aspartate in the rat
67. Calcium movements in traumatic brain injury: The role of glutamate receptor-operated ion channels
68. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain
69. Alteration in extracellular amino acids after traumatic spinal cord injury
70. Requirement for superoxide in excitotoxic cell death
71. Kainic acid-induced lipid peroxidation: Protection with butylated hydroxytoluene and U78517F in primary cultures of cerebellar granule cells
72. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline reduces glial loss and acute white matter pathology after experimental spinal cord contusion
73. The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides
74. Free radicals and brain damage
75. 4-Hydroxynonenal, a lipid peroxidation product, rapidly accumulates following traumatic spinal cord injury and inhibits glutamate uptake
76. High- and low-affinity NMDA receptor-binding sites in rat spinal cord: Effects of traumatic injury
77. Superoxide radicals play important roles in the pathogenesis of spinal cord injury
78. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms
79. Neurotoxic effects of excitatory amino acids in the mouse spinal cord: Quisqualate and kainate but not N-methyl-D-aspartate induce permanent neural damage
80. Reactive oxygen species inhibit high-affinity glutamate uptake: Molecular mechanism and neuropathological implications
81. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes
82. NBQX, a competitive non-NMDA receptor antagonist, reduces degeneration due to focal spinal cord ischemia
83. Apoptosis following spinal cord injury in rats and preventative effect of N-methyl-D-aspartate receptor antagonist
84. Changes of amino acid levels and aspartate distribution in the cervical spinal cord after traumatic spinal cord injury
85. Effect of kynurenate on functional deficits resulting from traumatic spinal cord injury
86. Evidence that local non-NMDA receptors contribute to functional deficits in contusive spinal cord injury
87. Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonist NBQX
88. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors
89. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma
90. The mechanosensitivity of spinal sensory neurons following intraspinal injections of quisqualic acid in the rat
91. Neuronal degeneration and spinal cavitation following intraspinal injections of quisqualic acid in the rat
92. Secondary injury mechanisms in acute spinal cord injury